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Two Types of Prothrombin in Vitamin K Deficiencl'
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The mode of action of vitanrin K and hence of vitamin K antagonists is essentially
unknown although recognition and management of drug induced or spontaneous
vitamin K deficiencies is of great medical importance.
In 1963 we postulated that vitamin K acts at a stage in coagulation factor synthesis
after the sSmthesis of the polypeptide chain per se (I). This conclusion is supported by
experiments conducted on this topic by other investigators (2,3, 4,5). We based our
assumption on the observation that parallel with the decrease of the coagulation
factors II, VII, IX and X the occurrence was observed of a Protein lnduced by
Zitamin K .4bsence or .4ntagonists (PIVKA). This protein was discerned because it
acted as a competitive inhibitor of factor X conversion. It was postulated that PI\IKA
was the product of polgreptide chain syrthesis unmodffied by the vitamin K depen-
dant mechanism. PIVKA was originally called preprothrombin, but a more neutral
name seems preferable. This communication is to report the finding of a slow genera-
tion of thrombin activity from PIVKA.
This slow generation seems to be at the basis of the discrepancy between the one-
and two-stage estimations of prothrombin (factor II) in stable anticoagulation. Biggs
et al. (6) claim the level of factor II to be 10-30o/o higher than that of factors VII, IX
and X, whereas Loeliger et al. (7) found all four factors to be mutually equally
lowered. Biggs et al. estimated factor ff in a two-stage procedure, Loeliger et al. used
a one-stage estimation method. The difference between these two methods lies in the
fact that in the two-stage procedure all the material able to produce thrombin is
converted into thrombin and measured as such, whereas the one-stage procedure
estimates the prothrombin content by measuring the initial rate of the reaction in
which prothrombin is rate-limiting (8), i. e. :
prothrombinase
prothrombin
A difficulty inherent to the two-stage procedure is that thrombin as it generates in
the mixture is inactivated by antithrombin III. The velocity of inactivation is pro-
portional to the concentrations of thrombin and antithrombin III (9). Hence the
amount of thrombin found with this method is dependant upon the concentrations of
antithrombin IIf as well as upon the concentrations of prothrombin.
To overcome this difficulty created. by the presence o? antithrombin III, we adopted
a two-stage procedure after elimination of antithrombin III (see legend to Fig. 1). The
thrombin generated then will not deteriorate to any extend for an appreciable time.
The level of thrombin that eventually develops is taken as a measure of the pro-
thrombin content in the samples tested.
Mixtures of pooled normal plasma (prepared from 30 infividuals) and Al(OH)t
adsorbed normal plasma were tested side by side with plasmas from patients with
absolute or drug-induced vitamin K deficiency. The amounts of thrombin obtained with
different dilutions of normal plasma were used to construct a reference curve. With
normal plasma and dilutions thereof containing between 100 and 2o/o prothrombin,
thrombin formation always was complete within 5 min. fn sfuiking contrast with this
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Eig.l. Thromb,in generat'ton i,n a,n anti,th,rombi,n I II Jree medi,um. From the samples to be t'ested we
prepared a euglobulin fraction, which contains a fixed fraction (approx. 50o/) of the procoagulants
of the original plasma and no antithrombin III (9). The euglobulin precipitate of 0.5 mI plasma is
dissoluted in 2.5 ml citra,ted Michaelisbuffer pI{ 7.4 (conc. of cilratre 22 mM), and thrombin is
generated in an mixture of equal amounts of euglobulin solution, CaCI, (10 mM final concentration),
human brain thromboplastin (prepared according to Owren and Aas, final dilution 1:30) and a
preparation containing 50o/o factor X und 76o/o factor VII and no other coagulation factors, pre-
pared from normal serum according to Prou-Wartelle (1, 2). a-O a) lower curve: thrombin
generated from plasma from a patient patient with severe vitamin K-deficiency (one-stage
factor II <zTd ; b) upper curve : thrombin generat'ed in the same plasma with 6 o/o normal plasma
added; x =-x c) upper curve : thrombin generated from normal plasma diluted 1 in 4; d) lower
curve: subtraction of the curves a and b.
(and completely unexpectedly) in preparations obtained from plasma from severely
vitamin K deficient patients (prothrombin level as assessed by the one-stage procedure
< 2% of normal) a slow thrombin generation was observed which in 60 min reached
levels of 20-30o/o of normal (Fig 1). This slow rise could not be attributed to deficien-
cies of the factors VII or X, as these factors were added in excess to the reaction
medium. Neither is this slow generation likely to be caused by an inhibition of the
conyersion of essentially normal prothrombin. In the first place because the anti-
coagulant circulating in vitamin K deficiency (c. q. PI\IKA) does not inhibit the
prothrombin --+ thrombin reaction (11). Secondly the thrombin generation curIg
obtained with a mixture of normal plasma and plasma from a severely vitamin K
deficient patient cannot be distinguished from the sum of the slowly rising curve
obtained. *ith the latter plasma alone and the normal quick rising curve as obtained
with a small amount of normal plasma present, (n'ig. 1).
It thus seems that in this medium normal prothrombin is activated normally and
that the slow formation of thrombin results from the activation of an abnormal
Drothrombin.
- 
X'ig.2 shows that a fiscrepancy between the one-stage and two-stage procedures is
found in vitamin K deficiency (spontaneous as well as coumarin induced), but not in
dilutions of normal plasma and disturbances of factor II level due to hepato-cellular
635
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Fig.2. Comparisonbetueen one-stage and, tuo-stage est'imat'ions oJ Ttrothrombi,n t dilutions of normal
plasma (note: these are used as a reference in both methods, the points therefore do not deviate
from a straight, line through the origin indicating a, 1 lo L relationship); O pooled plasmas from
30 patients anticoagulated to a different degreo by phenprocoumon intake; x plasmas from indi-
vidual patients with vitamin K deficiency, proven clinically afterwards by favourable reaction to
aclministrat'ion of vitamin Kr; I plasmas from individual patients with parenchymatous hepatic
disease but without vitamin I( deficiencv.
damage. The amount of excess thrombin in the two-stage test appears to be indepen-
dant of the level of anticoagulation c. q. severity of vitamin K deficiency; it approxim-
ately equals 20o/o of the normal factor II level. These results could be explained by the
hgrothesis that the one-stage determination of prothrombin was systematically
underestimated in plasma from vitamin K deficient patients e. g. by the occurrence of a
specific inhibitor of this determination. In previous experiments no eyidence of such
an inhibitor has been found, however (11 ).
Recent methodological investigations have shown that from the thrombin genera-
tion curve a reasonable estimate of the thrombin content can equally well be obtained
in the presence of antithrombin III. This is done by linear extrapolation to zero time of
a plot of the logarithm of thrombin concentration against incubation time (10).
We think the present experiments suggest the presence of two populations of
thrombin generating zymogens in vitamin K deficiency. Besides the normal zJrmogen
an abnormal, slowly activating species seems to be present. These observations fit well
with the observations of Josso and Nilehn & Ganroth that in vitamin K defieiency two
tlpes of electrophoretically different species can be distinguished that both show a
precipitation reaction with antibodies against human prothrombin. Assuming that
PIVKA has antigenic properties in common with prothrombin and that it is a zymogen
of thrombin as well, the concept of a two-step synthesis of the vitamin K dependant
coagulation factors holds well as an explanation for these observations.
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SummarY
In vitamin K deficiency (either absolute or induced by oral anticoagulantg) tlo
types of prothrombin occur. One is not distinguishable from normal prothrombin. It
glierates thrombin quickly in a medium in which the factors V, VII and X, thrombo-
plastin and Ca++ ari present in sufficient amounts. The other is converted into
lhrombin much more slowly under the same conditions. In the onestage prothrombin
assay only the first form is measured, in a two-stage prothrombin assay both forms are
estimated. This accounts for the well-knorvn discrepancy between these two tests in
vitamin K deficiency. The abnormal prothrombin can be considered one of the
Proteins Induced by Vitamin K Absence. The occurrence of this kind of proteins fits
in the concept of the action of vitamin K as a co-factor in a system that converts
polypeptide-precursors into coagulation factors.
R6sume
La d6ficience en vitamine K (soit absolue soit induite par les anticoagulants oraux)
provoque I'apparition de deux types de prothrombine. L'une ne peut 6tre distinguee
he h prothro-fio" normale. EilJdonne rapidement de Ia thrombine dans un milieu
conteiant les facteurs V, VII et X, Ia thromboplastine et le C,a++ en quantit6s
su{fisantes. L'autre dans les m6mes conditions, est convertie en thrombine beaucoup
plus lentement. La m6thode en un temps mesure seulement la premidre forme, la
-*etnodu 
en deux temps enregistre I'activit6 des deux formes. Cela rend compp de la
diff6rence bien gonnue entre ces deux systdmes de dosage, dans les cas de d6ficience
en vitamine K. f,a prothrombine anormale peut 6tre consid6r6e corlme une des
<r'Prot6ines Ind,uites,-1a Vitamine K 6tant Absente >. L'occurence de cette sorte de
prot6ines convient bien d la th6orie selon la quelle la vitamine K agrt corlme co-fac-
ieur dans Ie systdme qui convertit des polypeptides pr6curseurs en fa'steurs de
coagulation.
Zusammenlassung
Bei Vitamin K-Mangel (entweder absolut oder d.urch orale Antikoagulantien_in-
duziert) finden sich zwlei Typen von Prothrombin. Eines kann nicht von normalem
Prothrombin unterschied.en werden. Es bildet schnell Thrombin in einem Medium, in
dem die X'aktoren V, VII und X, Thromboplastin und Ca++ in ausreichenden Mengen
vorhanden sind. Das andere wird unter denselben Bedingungen viel langsamer in
Thrombin umgewand.elt. fn der Einstu-fen-Prothrombin-Bestimmungs_methode wird
nur die erste form gemessen, in einer Zweistufen-Methode werden beide Formen be-
stimmt. Dies erkki,ridie wohl bekannte Diskrepanz zwischen diesen beiden Testen bei
Vitamin K-Mangel. Das abnorme Prothrombin kann als einer der EiweiBkorper, die
d.urch Vitamin K-Mangel induziert werden, au{gefa$! werden. Das Vorkommen dieser
Art von Eiwei8korpern paBt in das Konzept der Wirkung des Vitamin K als eines
Kofaktors in dem System-, d.as PolSryeptid.vorstufen in Gerinnungsfaktoren umwandelt.
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